Publication: Obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats
Issued Date
2016-02-01
Resource Type
ISSN
14796805
00220795
00220795
Other identifier(s)
2-s2.0-84962159968
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Endocrinology. Vol.228, No.2 (2016), 85-95
Suggested Citation
Saranyapin Potikanond, Pinyada Rattanachote, Hiranya Pintana, Panan Suntornsaratoon, Narattaphol Charoenphandhu, Nipon Chattipakorn, Siriporn Chattipakorn Obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats. Journal of Endocrinology. Vol.228, No.2 (2016), 85-95. doi:10.1530/JOE-15-0333 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/43104
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats
Other Contributor(s)
Abstract
© 2016 Society for Endocrinology. The present study aimed to test the hypothesis that testosterone deprivation impairs osteoblastic insulin signaling, decreases osteoblast survival, reduces bone density, and that obesity aggravates those deleterious effects in testosterone-deprived rats. Twenty four male Wistar rats underwent either a bilateral orchiectomy (O, nZ12) or a sham operation (S, nZ12). Then the rats in each group were further divided into two subgroups fed with either a normal diet (ND) or a high-fat diet (HF) for 12 weeks. At the end of the protocol, blood samples were collected to determine metabolic parameters and osteocalcin ratios. The tibiae were collected to determine bone mass using microcomputed tomography and for osteoblast isolation. The results showed that rats fed with HF (sham-operated HF-fed rats (HFS) and ORX HF-fed rats (HFO)) developed peripheral insulin resistance and had decreased trabecular bone density. In ND-fed rats, only the ORX ND-fed rats (NDO) group had decreased trabecular bone density. In addition, osteoblastic insulin resistance, as indicated by a decrease in tyrosine phosphorylation of the insulin receptor and Akt, were observed in all groups except the sham-operated ND-fed rats (NDS) rats. Those groups, again with the exception of the NDS rats, also had decreased osteoblastic survival. No differences in the levels of osteoblastic insulin resistance and osteoblastic survival were found among the NDO, HFS, and HFO groups. These findings suggest that either testosterone deprivation or obesity alone can impair osteoblastic insulin signaling and decrease osteoblastic survival leading to the development of osteoporosis. However, obesity does not aggravate those deleterious effects in the bone of testosterone-deprived rats.